SCHEMBL208450

SCHEMBL208450

COC1CCC(N2CC[C@@H](Cc3c(Cl)cc(-c4ccc(C(=O)O)cc4)cc3Cl)C2=O)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.37
RARG P13631 1/20 0.35
PDE4A P27815 2/20 0.35
PDE4B Q07343 2/20 0.35
PDE4C Q08493 2/20 0.35
PDE4D Q08499 2/20 0.35
PRKAB2 O43741 1/20 0.35
PRKAG1 P54619 1/20 0.35
PRKAA2 P54646 1/20 0.35
PRKAA1 Q13131 1/20 0.35
PRKAG3 Q9UGI9 1/20 0.35
PRKAG2 Q9UGJ0 1/20 0.35
PRKAB1 Q9Y478 1/20 0.35
RXRA P19793 2/20 0.34
SSTR5 P35346 1/20 0.34
RXRB P28702 1/20 0.34
EPHX2 P34913 1/20 0.34
TSHR P16473 1/20 0.34
PARP1 P09874 1/20 0.34
PARP2 Q9UGN5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL208451 1.00 HSD11B1 (0.37) HSD11B1RARGPDE4APDE4BPDE4C
SCHEMBL208947 0.91 ALDH1A1 (0.37) HSD11B1PDE4APDE4BPDE4CPDE4D
SCHEMBL208948 0.91 ALDH1A1 (0.37) HSD11B1PDE4APDE4BPDE4CPDE4D
SCHEMBL208539 0.87 SRD5A2 (0.35) HSD11B1SSTR5TSHRCMA1
SCHEMBL208540 0.87 SRD5A2 (0.35) HSD11B1SSTR5TSHRCMA1
SCHEMBL209050 0.87 SRD5A2 (0.35) HSD11B1SSTR5TSHRCMA1
SCHEMBL209306 0.87 HSD11B1 (0.51) HSD11B1PDE4BPDE4DRXRASSTR5
SCHEMBL209156 0.87 SSTR5 (0.33) HSD11B1SSTR5TSHRCMA1
SCHEMBL208777 0.87 SSTR5 (0.33) HSD11B1SSTR5TSHRCMA1
SCHEMBL209157 0.87 SSTR5 (0.33) HSD11B1SSTR5TSHRCMA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2016047-B1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11- BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2013-08-28 EP disclosed
US-8088776-B2 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-01-03 US disclosed
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD11B2 HSD11B1 1/4885RARG 3282/4885PDE4A 1263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.